Crawford Pharmaceuticals has developed a new drug, Vaxidene. The target amount for a single dose of Vaxidene is 101 mg. Patients can receive as little as 94 mg or as much as 108 mg without experiencing any ill effects. Because of potential liability issues, Crawford has determined that it is imperative that manufacturing be able to provide Six Sigma quality levels. At present, the manufacturing process has a process mean of 101 mg and a standard deviation of 9.95 mg. a. The upper tolerance limit for Vaxidene is mg. (Enter your response as a whole number.) The lower tolerance limit for Vaxidene is mg. (Enter your response as a whole number.) b. The process capability ratio for Crawford's manufacturing process is (Enter your response rounded to three decimal places.) Crawford's manufacturing process capable of meeting the tolerance limits 99.7% of the time. c. In order to achieve exactly Six Sigma process capability levels, the standard deviation would need to be mg. (Enter your response rounded to two decimal places.)